Dysregulation of tRNA-derived small RNAs and their potential roles in lupus nephritis. 2021

Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
Department of Nephrology, 89657The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

OBJECTIVE Lupus nephritis (LN) is a major end-organ complication of systemic lupus erythematosus (SLE), and the molecular mechanism of LN is not completely clear. Accumulating pieces of evidence indicate the potential vital role of tRNA-derived small RNAs (tsRNAs) in human diseases. Current study aimed to investigate the potential roles of tsRNAs in LN. METHODS We herein employed high-throughput sequencing to screen the expression profiles of tsRNAs in renal tissues of the LN and control groups. To validate the sequencing data, we performed quantitative real-time PCR (qRT-PCR) analysis. Correlational analysis of verified tsRNAs expression and clinical indicators was conducted using linear regression. The potential target genes were also predicted. The biological functions of tsRNAs were annotated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. RESULTS Our findings revealed that the expression profiles of tsRNAs were significantly altered in the kidney tissues from LN patients compared with control. Overall, 160 tsRNAs were significantly dysregulated in the LN group, of which 79 were upregulated, whereas 81 were downregulated. Subsequent qRT-PCR results confirmed the different expression of candidate tsRNAs. Correlation analysis results found that expression of verified tsRNAs were correlated to clinical indicators. The target prediction results revealed that verified tsRNAs might act on 712 target genes. Further bioinformatics analysis uncovered tsRNAs might participate in the pathogenesis of LN through several associated pathways, including cell adhesion molecules, MAPK signaling pathway, PI3K-Akt signaling pathway and B cell receptor signaling pathway. CONCLUSIONS This study provides a novel insight for studying the mechanism of LN.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012343 RNA, Transfer The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains. Suppressor Transfer RNA,Transfer RNA,tRNA,RNA, Transfer, Suppressor,Transfer RNA, Suppressor,RNA, Suppressor Transfer
D019869 Phosphatidylinositol 3-Kinases Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell. PI-3 Kinase,Phosphatidylinositol-3-OH Kinase,PtdIns 3-Kinase,PI 3-Kinase,PI-3K,PI3 Kinases,PI3-Kinase,Phosphoinositide 3 Kinases,Phosphoinositide 3-Hydroxykinase,PtdIns 3-Kinases,3-Hydroxykinase, Phosphoinositide,Kinase, PI-3,Kinase, Phosphatidylinositol-3-OH,Kinases, PI3,Kinases, Phosphoinositide 3,PI 3 Kinase,PI3 Kinase,Phosphatidylinositol 3 Kinases,Phosphatidylinositol 3 OH Kinase,Phosphoinositide 3 Hydroxykinase,PtdIns 3 Kinase,PtdIns 3 Kinases
D063990 Gene Ontology Sets of structured vocabularies used for describing and categorizing genes, and gene products by their molecular function, involvement in biological processes, and cellular location. These vocabularies and their associations to genes and gene products (Gene Ontology annotations) are generated and curated by the Gene Ontology Consortium. Gene Ontology Project,Gene Ontologies,Gene Ontology Projects,Ontologies, Gene,Ontology Project, Gene,Ontology Projects, Gene,Ontology, Gene,Project, Gene Ontology,Projects, Gene Ontology

Related Publications

Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2020, Frontiers in pharmacology,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
November 2022, Genes & diseases,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2021, Frontiers in molecular biosciences,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2023, Frontiers in genetics,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2022, Frontiers in genetics,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
May 2024, Nature reviews. Molecular cell biology,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2022, Frontiers in physiology,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
January 2023, Journal of inflammation research,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
July 2023, Experimental & molecular medicine,
Yan Liang, and Ji Zhang, and Wenxian Qiu, and Bo Chen, and Ying Zhou, and Xiaoqian Chen, and Yangping Shentu, and Huidi Zhang, and Yongheng Bai, and Chaosheng Chen
December 2021, RNA biology,
Copied contents to your clipboard!